IL-3 Receptor Signaling Is Dispensable for BCR-ABL-induced Myeloproliferative Disease

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.2035020100
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Adoptive Immunotherapy of BCR-ABL-induced Chronic Myeloid Leukemia-Like Myeloproliferative Disease in a Murine Model

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Lipocalin 2 Is Required for BCR-ABL-induced Tumorigenesis

Oncogene
Cancer ResearchGeneticsMolecular Biology
2008English

Suppression of E-Protein Activity Interferes With the Development of BCR-ABL-mediated Myeloproliferative Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Genomic Mechanisms of P210 BCR-ABL Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

The SRC Homology-2 Protein SHB Modulates Focal Adhesion Kinase Signaling in a BCR-ABL Myeloproliferative Disorder Causing Accelerated Progression of Disease

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2014English

Calcium Signaling Is Dispensable for Receptor Regulation of Endothelial Barrier Function

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

MT1-MMP as a Downstream Target of BCR-ABL/ABL Interactor 1 Signaling: Polarized Distribution and Involvement in BCR-ABL-stimulated Leukemic Cell Migration

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

PECAM-1 Is Involved in BCR/ABL Signaling and May Downregulate Imatinib-Induced Apoptosis of Philadelphia Chromosome-Positive Leukemia Cells

International Journal of Oncology
Cancer ResearchOncology
2012English

BCR-ABL Tyrosine Kinase

Science-Business eXchange
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy